221 related articles for article (PubMed ID: 17631865)
1. The PGE2-induced inhibition of the PLD activation pathway stimulated by fMLP in human neutrophils is mediated by PKA at the PI3-Kgamma level.
Burelout C; Thibault N; Harbour D; Naccache PH; Bourgoin SG
Biochem Pharmacol; 2007 Sep; 74(5):730-41. PubMed ID: 17631865
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase gamma.
Burelout C; Thibault N; Levasseur S; Simard S; Naccache PH; Bourgoin SG
Mol Pharmacol; 2004 Aug; 66(2):293-301. PubMed ID: 15266020
[TBL] [Abstract][Full Text] [Related]
3. Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes.
Thibault N; Burelout C; Harbour D; Borgeat P; Naccache PH; Bourgoin SG
J Leukoc Biol; 2002 Feb; 71(2):367-77. PubMed ID: 11818459
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phospholipase D activation by CYL-26z in formyl peptide-stimulated neutrophils involves the blockade of RhoA activation.
Kuan YH; Lin RH; Tsao LT; Chen YL; Tzeng CC; Wang JP
Biochem Pharmacol; 2005 Sep; 70(6):901-10. PubMed ID: 16024001
[TBL] [Abstract][Full Text] [Related]
5. Calcium rather than protein kinase C is the major factor to activate phospholipase D in FMLP-stimulated rabbit peritoneal neutrophils. Possible involvement of calmodulin/myosin L chain kinase pathway.
Kanaho Y; Nishida A; Nozawa Y
J Immunol; 1992 Jul; 149(2):622-8. PubMed ID: 1624805
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. Distinct from the pathway for superoxide anion production.
Yasui K; Yamazaki M; Miyabayashi M; Tsuno T; Komiyama A
J Immunol; 1994 Jun; 152(12):5922-9. PubMed ID: 8207217
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; Salvi S; Regan JW
Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling.
Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF
Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492
[TBL] [Abstract][Full Text] [Related]
10. Monosodium urate-crystal-stimulated phospholipase D in human neutrophils.
Marcil J; Harbour D; Houle MG; Naccache PH; Bourgoin S
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):185-92. PubMed ID: 9882614
[TBL] [Abstract][Full Text] [Related]
11. The blockade of formyl peptide-induced respiratory burst by 2',5'-dihydroxy-2-furfurylchalcone involves phospholipase D signaling in neutrophils.
Wang JP; Chang LC; Hsu MF; Lin CN
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):166-74. PubMed ID: 12928764
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst by cirsimaritin involves inhibition of phospholipase D signaling in rat neutrophils.
Wang JP; Chang LC; Hsu MF; Chen SC; Kuo SC
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):307-14. PubMed ID: 12237743
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18.
Carrigan SO; Pink DB; Stadnyk AW
J Leukoc Biol; 2007 Dec; 82(6):1575-84. PubMed ID: 17724165
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by HAJ11 of respiratory burst in neutrophils and the involvement of protein tyrosine phosphorylation and phospholipase D activation.
Wang JP; Tsao LT; Raung SL; Hsu MF; Kuo SC
Br J Pharmacol; 1997 Jan; 120(1):79-87. PubMed ID: 9117103
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase A increases phospholipase D activity and inhibits phospholipase D activation by acetylcholine in tracheal smooth muscle.
Mamoon AM; Smith J; Baker RC; Farley JM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1188-95. PubMed ID: 10565841
[TBL] [Abstract][Full Text] [Related]
17. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
Eckert RE; Jones SL
J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
[TBL] [Abstract][Full Text] [Related]
18. Involvement of vicinal dithiols in differential regulation of fMLP and phorbol ester-activated phospholipase D in stimulated human neutrophils.
Planat V; Tronchere H; Record M; Ribbes G; Chap H
Biochem Biophys Res Commun; 1996 Jan; 218(3):847-53. PubMed ID: 8579603
[TBL] [Abstract][Full Text] [Related]
19. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.
Yu HP; Hsieh PW; Chang YJ; Chung PJ; Kuo LM; Hwang TL
Biochem Pharmacol; 2009 Oct; 78(8):983-92. PubMed ID: 19540209
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C activity is not involved in N-formylmethionyl-leucyl-phenylalanine-induced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: studies with a staurosporine analogue with improved selectivity for protein kinase C.
Kessels GC; Krause KH; Verhoeven AJ
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):781-5. PubMed ID: 8391255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
